Coinbase Pivots to On-Chain Assets for Long-Term Growth

Generated by AI AgentCoin WorldReviewed byRodder Shi
Tuesday, Oct 28, 2025 8:31 pm ET2min read
Speaker 1
Speaker 2
AI Podcast:Your News, Now Playing
Aime RobotAime Summary

- Coinbase delists MASK-USDT, MINA-USDT, and GMT-USDT to focus on on-chain assets amid market shifts.

- JPMorgan analysts link this move to long-term growth potential in a consolidating crypto ecosystem through Base blockchain monetization.

- Strategic pivot aligns with broader industry trends toward regulatory compliance and DeFi integration, as seen in Polymarket's regulated U.S. expansion.

- Delistings reflect Coinbase's effort to streamline offerings amid volatile markets and evolving investor priorities for blockchain transparency.

Coinbase Global Inc. announced it will delist several trading pairs, including MASK-USDT, MINA-USDT, and GMT-USDT, as part of a strategic shift to consolidate its offerings and align with evolving market dynamics. The move comes amid broader industry trends, including regulatory scrutiny, technological advancements, and shifting investor preferences. Analysts suggest the delistings reflect Coinbase's focus on expanding access to on-chain assets, a strategy that could position the exchange for long-term growth in a rapidly consolidating crypto ecosystem, according to

.

The decision to remove these pairs follows a period of volatility in the crypto markets.

, for instance, saw a 1.6% rise to $111,390 after the White House confirmed a high-stakes meeting between President Donald Trump and Chinese leader Xi Jinping in South Korea. The development eased concerns over U.S.-China trade tensions, which had previously triggered a selloff in cryptocurrencies, according to . While the delistings are not directly tied to this geopolitical news, they underscore Coinbase's efforts to streamline its platform amid a landscape where user behavior and regulatory clarity increasingly drive asset prioritization.

Coinbase's strategy aligns with JPMorgan's analysis, which highlights the exchange's potential to monetize decentralized finance (DeFi) through its Base blockchain. The bank estimates that Base's $34 billion token ecosystem could generate revenue via sequencer fees, offering a new revenue stream as traditional crypto trading volumes face headwinds. This pivot mirrors broader industry shifts, with platforms like Minidoge leveraging events such as October 25's global AMA to attract retail investors and build regional validation, as noted in

.

The delistings also occur as prediction markets gain regulatory clarity in the U.S. Polymarket, a blockchain-based betting platform, is preparing a regulated return to the U.S. market in late November, focusing on sports betting, according to

. The company's acquisition of QCX, a CFTC-licensed derivatives exchange, enables it to offer compliant trading on outcomes ranging from sports matches to macroeconomic data. This development signals a maturing market where blockchain transparency and traditional regulatory frameworks are converging, potentially reshaping how platforms like approach compliance and innovation.

While Coinbase's delistings may draw attention, they are part of a larger narrative of adaptation. The exchange's focus on on-chain assets-ranging from Bitcoin to Base-native tokens-positions it to capitalize on a sector projected to grow as decentralized finance matures. Meanwhile, competitors like Polymarket are leveraging regulatory partnerships to capture market share in sports betting, a $8.52 billion segment expected to expand at an 11.6% annual rate through 2025, according to Bloomberg.

The strategic recalibration comes at a pivotal time for crypto. As institutions and retail investors alike seek clarity amid regulatory shifts, Coinbase's moves reflect a balancing act between innovation and compliance. The delistings, while specific, are emblematic of a broader industry-wide effort to align with a future where blockchain technology and traditional finance increasingly intersect.

Comments



Add a public comment...
No comments

No comments yet